Metrics raised 5
- Life insurance individual FIP 3-year CAGR target set at 20%+ (new 3-year target)
- Life insurance VNB margin 3-year target raised to >20% (from 15.1% current)
- HFC AUM target raised to ₹1 lakh crore+ in 8–10 quarters (from ₹51,833 crore current)
- HFC ROE target raised to ~13% by Q4 FY27 and ~15% in 8–10 quarters (from 11.29% current)
- Gold loan branch target set at 200–300 by March 2027, scaling to ~1,000 over 3 years (new target)
Metrics cut 2
- HFC FY27 OpEx/AUM guidance reduced to 2.15–2.19% (from 2.21% in Q1 FY27)
- Health insurance FY27 combined service coverage ratio target reduced to 100% (from 104% in Q1 FY27)
Event Participants
Executives (6)
Bala, Kamlesh Rao, Mayank, Pankaj, Rakesh, Vishakha Mulye
Analysts (6)
Aayush Ailawadi (Nomura), Abhijit Tibrewal (Motilal Oswal), Avinash Singh (Emkay Global), Chintan Shah (ICICI Securities), Nischint (Kotak), Raghav Garg (Ambit Capital)
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Consolidated revenue | +29% YoY | Absolute value not disclosed; broad-based growth across lending, insurance and AMC businesses. |
| Consolidated PAT | ₹1,175 crore | +40% YoY; driven by strong lending/insurance profitability and AMC scale. |
| NBFC AUM | ₹167,456 crore | +28% YoY, +5% QoQ; retail and SME now 72% of disbursements (vs 68% Q4 FY26). |
| NBFC disbursements | ₹21,201 crore | +34% YoY; personal & consumer +41% YoY, MSME +37% YoY. |
| Personal & consumer AUM | ₹23,267 crore | +41% YoY, +9% QoQ; 14% of total AUM (+136bps YoY); GS3 at 1.2%. |
| MSME AUM | ₹95,099 crore | +31% YoY; 57% of total AUM; 80% secured; GS3 at 1.1% (-50bps YoY). |
| Corporate segment AUM | — | +16% YoY; 29% of total portfolio; GS2+GS3 improved 40bps YoY. |
| HFC AUM | ₹51,833 crore | +50% YoY, +9% QoQ; crossed ₹50,000 crore milestone during the quarter. |
| HFC disbursements | ₹7,515 crore | +39% YoY; ABG ecosystem contributed 16.2% of retail disbursements. |
| AMC average AUM (incl. alternatives) | ₹6.28 lakh crore | +48% YoY; includes SIC and EPFO mandates. MF QAAUM ₹4.82 lakh crore, +6% YoY; equity QAAUM ₹1.9 lakh crore, +10% YoY. |
| Group closing AUM | Crossed ₹10 lakh crore | Management stated closing total assets under management crossed ₹10 lakh crore as of June 30, 2026. |
| Life insurance AUM | ₹117,487 crore | +13% YoY; 24% in equity; group AUM ₹30,000 crore (26% of total AUM). |
| Life insurance individual FYP | +20% YoY | Against industry +16% and private industry +15%; proprietary +7%, partnership +25%. |
| Health insurance gross premium (sales basis) | ₹296 crore | +50% YoY; SAHI market share 16.2% vs 14.2% (+200bps YoY). |
| NBFC NII | ₹2,377 crore | +28% YoY, +9% QoQ. |
| NBFC NIM (incl. fees) | 6.07% | Stable QoQ vs 6.08%; fee income -3bps, cost of funds benefit +5bps. |
| NBFC ROA | 2.39% | +14bps YoY, +8bps QoQ. |
| NBFC credit cost | 1.03% | -27bps YoY; cohort-level calibrations over past 18–24 months. |
| NBFC GS2+GS3 | 2.4% | -127bps YoY; 72% of book secured; provision cover 48.2% (+40bps QoQ). |
| HFC PBT | ₹300 crore | +95% YoY; ROA 2.12%, ROE 11.29%. |
| HFC Stage 3 / Stage 2+3 | 0.41% / 0.78% | Best-in-class asset quality; Stage 3 improved further. |
| Life insurance VNB margin | 15.1% | +756bps YoY from 7.5%; driven by non-par, protection, annuity mix and rider attachment. |
| Health insurance combined service coverage ratio (IFRS) | 104% | vs 108% prior year; combined ratio 106% vs 107%. IFRS PAT ₹18 crore vs loss of ₹28 crore. |
| AMC revenue / PAT | ₹620 crore / ₹309 crore | vs ₹560 crore / ₹277 crore in Q1 FY26. |
| Life insurance solvency | 201% | Adequately capitalized. |
| Capital raise (ABCL) | ₹4,000 crore | Preferential allotment — ₹3,080 crore from promoters, ₹920 crore from IFC; 87.5% earmarked for NBFC growth. |
| Capital raise (HFC) | ₹2,050 crore | Primary infusion from Advent International completed during the quarter. |
Geographic & Segment Commentary
NBFC (Aditya Birla Finance): AUM reached ₹167,456 crore (+28% YoY) with PAT of ₹927 crore (+35% YoY, +12% QoQ). Growth led by retail/SME disbursements (+39% YoY); unsecured business loan disbursements (incl. first tranche of LoC) reached ₹2,445 crore. Asset quality stayed strong — GS3 for personal & consumer 1.2%, MSME 1.1%, unsecured business loans 1.1%. Company entering gold loans in Q2 FY27 with 200–300 branches planned by March 2027.
HFC (Aditya Birla Housing Finance): AUM crossed ₹50,000 crore to ₹51,833 crore (+50% YoY); disbursements ₹7,515 crore (+39% YoY). PBT nearly doubled YoY to ₹300 crore. OpEx/AUM at 2.21% (vs 2.40% prior year), guided to 2.15–2.19% for FY27. Branch expansion ramping — 50 new branches launched in FY27 so far, 80–100 more planned this year. Partner base crossed 40,000.
AMC (Aditya Birla Sun Life AMC): Average AUM incl. alternatives crossed ₹6 lakh crore to ₹6.28 lakh crore (+48% YoY), helped by SIC and EPFO mandates. Equity MF QAAUM ₹1.9 lakh crore (+10% YoY), equity mix 46.5%. Passive QAAUM +14% YoY, ETF QAAUM +47% YoY vs industry +29%. Received Gift City retail license; new FIA and retail product launches planned.
Life Insurance (Aditya Birla Sun Life Insurance): Individual FYP grew 20% YoY; group life premium +74% YoY (private industry +46%). Traditional product mix rose to 71% (ULIP 29%), supporting VNB margin expansion to 15.1%. Group term life business continues at 20%+ ROE; ranking #2 in ULIP AUM at ₹70,000+ crore. 13-month persistency 83%, renewal premium +19%, 83% of renewals collected digitally.
Health Insurance (Aditya Birla Health Insurance): Gross premium on sales basis ₹296 crore (+50% YoY), fastest-growing SAHI with 16.2% market share (+200bps). Retail +47%, proprietary channels +56%, corporate +55%. Reported first IFRS profit of ₹18 crore vs loss of ₹28 crore YoY. 74% of cashless claims processed via AI engine; 320,000+ high-risk lives under intervention, delivering >30% loss-ratio improvement.
Company-Specific & Strategic Commentary
Capital Infusion & Deployment: ABCL raised ₹4,000 crore via preferential allotment (₹3,080 crore promoter/promoter group, ₹920 crore IFC). 87.5% earmarked for NBFC growth; balance for insurance subsidiaries and general corporate purposes. HFC received ₹2,050 crore primary capital infusion from Advent International. Management stated no further equity raise is planned for the next 12 months, with capital provided for 3-year growth plans.
Gold Loan Foray: Final stages of operational readiness complete; launching in Q2 FY27. Plans 200–300 standalone gold loan branches by March 2027, scaling to ~1,000 branches over three years. Will be a pan-India operation, adding a secured, collateral-backed retail product to the portfolio.
Digital & AI Adoption: AI positioned as a "core operating layer" across underwriting, sales, voice calling, audit, compliance, and customer service. NBFC: 63% of contact center interactions and 71% of service emails processed via straight-through processing; conversational analytics at 100% automation. HFC: 13 AI use cases live, including Fintellect (AI-generated credit memos) and Partner One. Life: SARAL AI program for issuance, underwriting, servicing; 100% digital onboarding, 97% customer self-service. Health: AI claims engine handles 74% of cashless claims.
Distribution Expansion — HFC: 50 new branches launched in FY27, with new cohorts achieving mature-branch productivity earlier than expected. Partner franchise crossed 40,000 partners. Distribution is the primary growth lever toward the ₹1 lakh crore AUM target.
AMC Product & Franchise Expansion: Actively building passive business with a strengthened team; ETF QAAUM +47% YoY. Launching ABSL MC Flexi Cap Fund and two new FIA offerings (Equity Long Short and Equity Next Top 100 Long Short). Gift City license enables NRI/global investor access to India and global markets.
Life Insurance Product Mix Shift: Traditional business (incl. protection) now 71% of individual mix; annuity contributes 16% of retail new business. Partnership business grew 25% across all 11 bank partners; proprietary direct business "doing pretty well" while agency transformation continues.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Life insurance individual FIP | 20%+ CAGR over next 3 years | Management committed; to be achieved with VNB margin above 20% and absolute VNB doubling in 3 years. |
| Life insurance VNB margin | >20% (3-year target) | Current 15.1%; expansion driven by product mix (non-par, protection, annuity) and rider attachments. |
| HFC AUM | ₹1 lakh crore+ in 8–10 quarters | Current ₹51,833 crore; supported by branch expansion, partner base, and Advent capital. |
| HFC ROE | ~13% by Q4 FY27; ~15% in 8–10 quarters | Near-term ROE 11.29% due to fresh capital; ROA expected range-bound while leverage builds. |
| HFC OpEx/AUM | 2.15%–2.19% for FY27 | Branch and manpower ramp-up offset by productivity gains from AI and digital platforms. |
| Health insurance combined service coverage ratio | 100% for FY27 | From 104% in Q1 FY27; management "endeavoring" to achieve on IFRS basis this year. |
| Gold loan branches | 200–300 by March 2027; ~1,000 in 3 years | Going live in Q2 FY27; pan-India standalone branches. |
| Capital raise | No further equity raise expected for 12 months | ABCL, HFC and insurance entities capitalised for next 3 years; 87.5% of ₹4,000 crore earmarked for NBFC growth. |
Risks & Constraints
| Risk | Context |
|---|---|
| Macroeconomic uncertainty | Rising input and energy costs make growth "very uncertain" despite strong domestic demand and credit growth. Management remains cautiously optimistic on medium-term opportunities. |
| Regulatory risk on credit-life/insurance attachment | Fee income (+50% YoY in NBFC) partly driven by insurance attachment; potential regulatory curbs on credit-life payouts could pressure fee yields. Management called it an industry-level risk and said ABCL would work to mitigate if it materialises. |
| Unsecured portfolio concentration | Personal & consumer plus unsecured business loans form ~25% of NBFC book. GS3 is low (1.1–1.2%) but 40% of unsecured GS3 is covered by government guarantee schemes; continued cohort calibration is required to maintain quality. |
| HFC ROE dilution | ₹2,050 crore primary capital infusion temporarily lowers ROE to 11.29%. Recovery to ~13% by Q4 FY27 and ~15% in 8–10 quarters depends on AUM scaling to ₹1 lakh crore without material OpEx or credit-cost creep. |
| Asset quality volatility | Management acknowledged "volatile market conditions and uncertainties in operating environment," though lending asset quality remained strong with NBFC GS2+GS3 at 2.4% and HFC Stage 3 at 0.41%. |
Q&A Highlights
NBFC Margins & Yield Expansion
- Question: Are loan spreads declining after adjusting for liquidity and fee income? (Raghav Garg, Ambit Capital)
- Answer: Yields are stable QoQ; NIM incl. fees 6.07% vs 6.08% last quarter, with fee income lower by ~3bps and cost of funds better by ~5bps. (Rakesh)
- Question: When will margins pick up given personal & consumer mix is rising? (Chintan Shah, ICICI Securities; Abhijit Tibrewal, Motilal Oswal)
- Answer: Unsecured business share is ~24–25%; yield expansion will come when mix reaches 27–30%. Personal & consumer EIR is 16.2% vs 16.5% four quarters back. Focus is on risk-adjusted returns — credit cost is down 27bps YoY — and ABCL will not loosen underwriting filters to chase yields. (Rakesh)
HFC OpEx, Branch Expansion and ROE Recovery
- Question: Will branch expansion costs hit P&L more in Q2? (Raghav Garg, Ambit Capital)
- Answer: Branches opened throughout Q1; OpEx/AUM 2.21%, guided to 2.15–2.19% for FY27. New branches are achieving mature productivity earlier than expected. (Pankaj)
- Question: When will ROE return to 15%? (Chintan Shah, ICICI Securities)
- Answer: Current ROE 11.29% reflects the Advent capital infusion. Expected ~13% by Q4 FY27 and ~15% in 8–10 quarters as AUM scales to ₹1 lakh crore. Existing capital is sufficient for that target. (Pankaj)
Fee Income Drivers & Credit-Life Regulatory Risk
- Question: What is driving the 50% YoY growth in fee income, and is there regulatory risk from credit-life attachment? (Avinash Singh, Emkay Global)
- Answer: Fee income is driven by processing fees and insurance attachments. Any regulatory change on credit-life would be industry-wide; ABCL would attempt to mitigate wherever possible. (Rakesh)
Gold Loan Foray & Scaling Plan
- Question: What is the branch target and are acquisitions under consideration? (Avinash Singh, Emkay Global; Aayush Ailawadi, Nomura)
- Answer: Going live in Q2 FY27; 200–300 standalone branches by March 2027 and ~1,000 over three years, pan-India. Base plan is organic, but value-accretive small acquisitions would be evaluated. (Rakesh; Vishakha Mulye)
Capital Allocation
- Question: How will the ₹4,000 crore raise be deployed, and are further raises likely? (Nischint, Kotak)
- Answer: 87.5% allocated to NBFC growth objectives; balance 12.5% for insurance subsidiaries and general corporate purposes. No further capital raise is envisaged at ABCL, HFC or other entities for the next 12 months; capital for 3-year growth plans is in place. (Vishakha Mulye)
Life Insurance Margin Expansion & Proprietary Growth
- Question: What drove the sharp VNB margin expansion, and why is proprietary business lagging? (Nischint, Kotak)
- Answer: Riders alone added ~1.5–2% to margins; ULIP mix controlled, annuity and non-par products growing, and half of the growth came from productivity (no incremental cost). Partnership/bancassurance is growing faster than proprietary across the industry; ABSLI's direct business is doing well and branch count will grow ~10% this year. (Kamlesh Rao)
Health Insurance HealthReturns Economics & Compliance
- Question: Do lower loss ratios and better persistency fully offset HealthReturns rewards — is the cohort value-accretive? (Aayush Ailawadi, Nomura)
- Answer: Yes — the HealthReturns cohort has ~6–7% lower loss ratios and 11% better persistency, making it accretive at the core portfolio level versus non-participating books. (Mayank)
- Question: Are UM guidelines being complied with? (Nischint, Kotak)
- Answer: The company is well within the UM guidelines. (Mayank)
Asset Quality Risk Markers
- Question: Any segment showing stress despite better-than-expected Q1 risk metrics? (Abhijit Tibrewal, Motilal Oswal)
- Answer: Monthly cohort-level and through-the-door monitoring is in place; high-risk segments and cohorts are eliminated proactively before they flow into the portfolio. No material stress flagged. (Rakesh)
Key Takeaway
Aditya Birla Capital delivered a strong Q1 FY27, with consolidated PAT up 40% YoY to ₹1,175 crore and revenue growth of 29%. The lending businesses drove the headline: NBFC AUM rose 28% to ₹167,456 crore with ROA at 2.39% and credit cost down 27bps to 1.03%, while HFC crossed ₹50,000 crore in AUM (+50% YoY) with PBT nearly doubling to ₹300 crore. Insurance margins improved sharply — life VNB margin hit 15.1% (+756bps YoY), and health turned IFRS-profitable at ₹18 crore vs a ₹28 crore loss. AMC AUM incl. alternatives crossed ₹6.28 lakh crore (+48% YoY) on EPFO/SIC mandates, with group closing AUM crossing ₹10 lakh crore. Strategically, ABCL raised ₹4,000 crore (87.5% earmarked for NBFC growth), completed Advent's ₹2,050 crore HFC infusion, and announced a gold loan entry with 200–300 branches planned by March 2027. Management guided to 20%+ life VNB margins, HFC AUM of ₹1 lakh crore+ in 8–10 quarters, and health combined service coverage of 100% in FY27, while ruling out further capital raises in the next 12 months. Key watchpoints are regulatory risk around credit-life fee income, unsecured mix scaling, and HFC ROE recovery from 11.29% toward the 15% target.